APA (7th ed.) Citation

H, G., F, J., J, G., V, B., L, A., & A, C. (2026). The impact of elexacaftor-tezacaftor-ivacaftor on cardiometabolic risk factors: A systematic review. European respiratory review : an official journal of the European Respiratory Society, 35(179), . https://doi.org/10.1183/16000617.0197-2025

Chicago Style (17th ed.) Citation

H, Girouard, Jaber F, Gharib J, Boudreau V, Alexandre-Heymann L, and Coriati A. "The Impact of Elexacaftor-tezacaftor-ivacaftor on Cardiometabolic Risk Factors: A Systematic Review." European Respiratory Review : An Official Journal of the European Respiratory Society 35, no. 179 (2026). https://doi.org/10.1183/16000617.0197-2025.

MLA (9th ed.) Citation

H, Girouard, et al. "The Impact of Elexacaftor-tezacaftor-ivacaftor on Cardiometabolic Risk Factors: A Systematic Review." European Respiratory Review : An Official Journal of the European Respiratory Society, vol. 35, no. 179, 2026, https://doi.org/10.1183/16000617.0197-2025.